(Reuters) -British drugmaker GSK said on Wednesday administration of its respiratory syncytial virus (RSV) vaccine and ...

Researchers have found evidence that low oxygen levels in tumors could actually enhance some of the body's immune responses against cancer, in contrast with the general paradigm that hypoxia ...

Children under 5 years old have a weaker immune response to COVID-19 compared with older children and adults, new research ...

Activation of macrophage TLR4 by bacterial endotoxins is important for the progression of sepsis, but the underlying ...

A collaboration between four MIT groups, led by principal investigators Laura L. Kiessling, Jeremiah A. Johnson, Alex K.

The University of Arkansas for Medical Sciences (UAMS) received a five-year $2,195,685 federal grant to study how modulating ...

Researchers discovered that SARS-CoV-2-specific T and B cells in long COVID patients are maintained for two years, similar to ...

The five-year, $2,195,685 million federal grant will help researchers study a link between the body’s immune response and ...

Emory researchers are the first to show unprecedented control of SIV replication and decay of viral reservoirs by combining a ...

GSK released data from a Phase 3 trial evaluating the co-administration of Arexvy and Shingrix vaccines in adults 50+. The ...

A collaboration between four MIT groups, led by principal investigators Laura L. Kiessling, Jeremiah A. Johnson, Alex K.

New study demonstrates that one type of lipid is so critical for immune evasion that certain cancers cannot proliferate without them. Modulating intake of dietary lipids could open up an avenue for ...